Neochord DS1000 System Successfully Treats 20th Patient in Combination with Other Beating Heart Procedures
30 avr. 2018 09h00 HE
|
NeoChord, Inc.
Nearly 1,000 patients treated with the DS1000 SystemReports acceleration in two transcatheter mitral repair programs ST. LOUIS PARK, Minn., April 30, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc., a...
NeoChord Announces a Research Collaboration with the Skirball Center for Innovation at the Cardiovascular Research Foundation
22 janv. 2018 16h02 HE
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Jan. 22, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative...
Andrew ElBardissi, M.D. Named to NeoChord Board of Directors
10 juil. 2017 16h03 HE
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., July 10, 2017 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative...
NeoChord Names J. Alex Martin Chairman of the Board
23 janv. 2017 16h03 HE
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Jan. 23, 2017 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of minimally invasive valve repair for degenerative...
First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation
09 nov. 2016 16h03 HE
|
NeoChord, Inc.
NeoChord reports initial use of DS1000 System in U.S. Pivotal TrialResults from initial enrollment success “very promising”Three U.S. Centers poised for initial trial enrollment ST. LOUIS PARK,...